Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
50
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Aneta Cymbaluk-Płoska1 Department of Gynecological Surgery and Gynecological Oncology of Adults and AdolescentsCorrespondence[email protected]
,
Anita Chudecka-Głaz1 Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents
,
Ewa Pius-Sadowska2 Department of General Pathology, Pomeranian Medical University
,
Agnieszka Sompolska-Rzechuła3 Department of Statistics, West Pomeranian University of Technology, Szczecin, Poland
,
Bogusław Machaliński2 Department of General Pathology, Pomeranian Medical University
,
Anna Surowiec1 Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents
&
Janusz Menkiszak1 Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents
 show all
Pages 3169-3175 | Published online: 27 Jun 2017

References

  • FelixASYangHPBellDWShermanMEEpidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influencesAdv Exp Med Biol201794334627910063
  • AlcazarJLPinedaLMartinez-Astorquiza CorralTTransvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approachesJ Gynecol Oncol201526320120726197857
  • SanjuanACoboTPahisaJPreoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen sectionInt J Gynecol Cancer200616138539016445663
  • LiXGaoYTanMExpression of HE4 in endometrial cancer and its clinical significanceBiomed Res Int2015201543746826539494
  • WangDWangDWangNLongZRenXLong non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathwayCell Physiol Biochem2016403–464465627898420
  • AngioliRCapriglioneSScalettaGThe role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up programTumour Biol20163744973497826531723
  • LiuXZhaoFHuLSunYValue of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypesOnco Targets Ther201581239124326060409
  • GasiorowskaEMagnowskaMIzyckaNWarcholWNowak-MarkwitzEThe role of HE4 in differentiating benign and malignant endometrial pathologyGinekol Pol201687426026427321096
  • HuLDuSGuoWChenDLiYComparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in endometrial cancer: a meta-analysisInt J Gynecol Cancer201626233134026807564
  • BieYZhangZDiagnostic value of serum HE4 in endometrial cancer: a meta-analysisWorld J Surg Oncol20141216924885319
  • DengLGaoYLiXExpression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinomaJ Exp Clin Cancer Res20153419626362938
  • ChenSZongZHWuDDSunKXLiuBLZhaoYThe role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progressionMol Carcinog201656413611371
  • Talvensaari-MattilaASantalaMSoiniYTurpeenniemi-HujanenTPrognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinomaAnticancer Res2005256B4101410516309203
  • Honkavuori-ToivolaMSantalaMSoiniYTurpeenniemi-HujanenTTalvensaari-MattilaACombination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinomaDis Markers201335426126624344400
  • GuoWChenGZhuCWangHExpression of matrix metalloproteinase-2, 9 and it’s tissue inhibitor-1, 2 in endometrial carcinomaZhonghua Fu Chan Ke Za Zhi2002371060460712487935
  • BignottiERagnoliMZanottiLDiagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsBr J Cancer201110491418142521468050
  • BrennanDJHackethalAMetcalfAMANECS GroupSerum HE4 as a prognostic marker in endometrial cancer – a population based studyGynecol Oncol2014132115916524211402
  • AbdallaNPiorkowskiRStanirowskiPSlomkaACendrowskiKSawickiWAssessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancerPrz Menopauzalny201615313313727980523
  • DobrzyckaBMackowiak-MatejczykBTerlikowskaKMKinalskiMTerlikowskiSJUtility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomyAdv Med Sci2016611232726344910
  • CapriglioneSPlottiFMirandaAFurther insight into prognostic factors in endometrial cancer: the new serum biomarker HE4Expert Rev Anticancer Ther201717191827892774
  • KemikPSaatliBYildirimNDiagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancerGynecol Oncol20161401646926607777
  • YilmazSAAltinkayaSOKerimogluOSThe role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesionsJ Obstet Gynaecol2017371586328006994
  • KarahanNGuneyMBaspinarSOralBKapucuogluNMunganTExpression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinomaEur J Gynaecol Oncol200728318418817624083
  • GraesslinOCortezAFauvetRLorenzatoMBirembautPDaraiEMetalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation studyAnn Oncol200617463764516407419
  • LiSShenXYangZClinical significance of MMP2 overexpression in endometrial adenocarcinomaNan Fang Yi Ke Da Xue Xue Bao201434342342524670463

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.